Calcitonin gene-related peptide is a depressor of deoxycorticosterone-salt hypertension in the rat

被引:65
|
作者
Supowit, SC [1 ]
Zhao, HW [1 ]
Hallman, DM [1 ]
DiPette, DJ [1 ]
机构
[1] UNIV TEXAS,MED BRANCH,DEPT HUMAN BIOL CHEM & GENET,GALVESTON,TX 77550
关键词
calcitonin gene-related peptide; blood pressure; hypertension; experimental; mineralocorticoids; neuropeptides;
D O I
10.1161/01.HYP.29.4.945
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Calcitonin gene-related peptide (CGRP) is a potent vasodilator neuropeptide. We previously demonstrated that neuronal CGRP expression is significantly increased in deoxycorticosterone (DOC)-salt hypertensive rats. To determine the hemodynamic role of CGRP in this setting, we used CGRP(8-37) a specific CGRP receptor antagonist. DOG-salt hypertension was induced in Sprague-Dawley rats. To control for DOC pellet implantation, left nephrectomy, and/or saline drinking water, we also studied four normotensive groups. Four weeks after the initiation of each protocol, all rats had intravenous (for drug administration) and arterial (for continuous mean arterial pressure monitoring) catheters surgically placed and were studied in the conscious, unrestrained state. Baseline mean arterial pressure was higher in the DOG-salt than normotensive rats (175 +/- 5 versus 119 +/- 4 mm Hg, P<.001). Vehicle administration did not alter mean arterial pressure in any group, and CGRP(8-37) administration (bolus doses of 3.2x10(4) or 6.4x10(4) pmol/L) did not change mean arterial pressure in the four normotensive groups. However, CGRP(8-37) administration to the DOG-salt rats rapidly and significantly increased mean arterial pressure at both the lower dose (9 +/- 1 mm Hg, P<.001) and higher dose (14 +/- 1 mm Hg, P<.001). In addition, the increase in mean arterial pressure between the two CGRP(8-37) doses was also significant (P<.01), indicating a dose-dependent response. We conclude that the increase in neuronal CGRP expression in DOC-salt hypertension plays a compensatory vasodilator role to attenuate the elevated blood pressure. These results provide the first conclusive evidence that CGRP plays a direct role in DOC-salt hypertension.
引用
收藏
页码:945 / 950
页数:6
相关论文
共 50 条
  • [31] CALCITONIN GENE-RELATED PEPTIDE
    DOCKRAY, GJ
    ISI ATLAS OF SCIENCE-PHARMACOLOGY, 1988, 2 (01): : 40 - 45
  • [32] BIOLOGICAL ACTIONS OF HUMAN AND RAT CALCITONIN AND CALCITONIN GENE-RELATED PEPTIDE
    LENZ, HJ
    RIVIER, JE
    BROWN, MR
    REGULATORY PEPTIDES, 1985, 12 (02) : 81 - 89
  • [33] CALCITONIN GENE-RELATED PEPTIDE
    不详
    LANCET, 1985, 2 (8445): : 25 - 26
  • [34] ONTOGENY OF CALCITONIN GENE-RELATED PEPTIDE AND CALCITONIN IN THE RAT-THYROID
    NITTA, K
    KITO, S
    KUBOTA, Y
    GIRGIS, SI
    HILLYARD, CJ
    MACINTYRE, I
    INAGAKI, S
    HISTOCHEMISTRY, 1986, 84 (02) : 139 - 143
  • [35] Calcitonin gene-related peptide (8-37) does not antagonize calcitonin gene-related peptide in rat spinal cord
    Xu, XJ
    WiesenfeldHallin, Z
    NEUROSCIENCE LETTERS, 1996, 204 (03) : 185 - 188
  • [36] Calcitonin gene-related peptide (CGRP) and its role in hypertension
    Smillie, Sarah-Jane
    Brain, Susan D.
    NEUROPEPTIDES, 2011, 45 (02) : 93 - 104
  • [37] Pathophysiology and therapeutic possibilities of calcitonin gene-related peptide in hypertension
    Marquez-Rodas, I.
    Longo, F.
    Rothlin, R. P.
    Balfagon, G.
    JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY, 2006, 62 (01) : 45 - 56
  • [38] Attenuated response to calcitonin gene-related peptide in essential hypertension
    Lindstedt, I
    Edvinsson, ML
    Edvinsson, L
    JOURNAL OF HYPERTENSION, 2005, 23 : S402 - S402
  • [39] SUPPRESSION OF RAT DEOXYCORTICOSTERONE-SALT HYPERTENSION BY KALLIKREIN-KININ SYSTEM
    MAJIMA, M
    KATORI, M
    HANAZUKA, M
    MIZOGAMI, S
    NAKANO, T
    NAKAO, Y
    MIKAMI, R
    URYU, H
    OKAMURA, R
    MOHSIN, SSJ
    OHISHI, S
    HYPERTENSION, 1991, 17 (06) : 806 - 813
  • [40] Enhanced depressor and hyperemic responses to calcitonin gene-related peptide in spontaneously hypertensive rats
    Yamada, P
    Ishikawa, T
    Fujimori, A
    Miyauchi, T
    Goto, K
    PEPTIDES, 1998, 19 (04) : 697 - 701